Vaxneuvance - direct healthcare professional communication (DHPC)

Pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)
DHPCHuman

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

Περί

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Έγγραφα

Direct healthcare professional communication (DHPC): Vaxneuvance (pneumococcal polysaccharide conjugate vaccine) suspension for injection: Important information regarding the potential for breakage of Vaxneuvance pre-filled syringes

English (EN) (824.22 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Key facts

Medicine name
Vaxneuvance
Active substance
Pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)
Therapeutic area (MeSH)
Pneumococcal Infections
Regulatory outcome
Maintenance
DHPC type
Quality defect
Human ATC codes
J07AL02
Dissemination date

Share this page